6,624 Shares in Tempus AI, Inc. $TEM Purchased by HighTower Advisors LLC

HighTower Advisors LLC purchased a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the first quarter, according to its most recent filing with the SEC. The fund purchased 6,624 shares of the company's stock, valued at approximately $320,000.

Other large investors have also bought and sold shares of the company. Wells Fargo & Company MN lifted its stake in Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after acquiring an additional 278 shares in the last quarter. Stifel Financial Corp lifted its position in shares of Tempus AI by 935.1% in the 4th quarter. Stifel Financial Corp now owns 39,810 shares of the company's stock worth $1,344,000 after acquiring an additional 35,964 shares during the period. Tudor Investment Corp ET AL bought a new position in shares of Tempus AI during the 4th quarter worth approximately $348,000. Comerica Bank lifted its position in shares of Tempus AI by 342.5% during the 4th quarter. Comerica Bank now owns 112,145 shares of the company's stock worth $3,786,000 after buying an additional 86,800 shares during the period. Finally, Alyeska Investment Group L.P. bought a new position in shares of Tempus AI during the 4th quarter worth approximately $8,075,000. Institutional investors own 24.22% of the company's stock.

Analyst Upgrades and Downgrades

TEM has been the subject of several research reports. BTIG Research lifted their target price on Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research note on Wednesday, August 20th. Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Needham & Company LLC restated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research note on Friday, August 8th. HC Wainwright started coverage on shares of Tempus AI in a report on Tuesday. They issued a "buy" rating and a $90.00 target price for the company. Finally, Morgan Stanley upped their price objective on Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research note on Tuesday, August 12th. Seven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, Tempus AI has an average rating of "Moderate Buy" and an average price target of $69.50.

Tempus AI Trading Up 3.3%

TEM stock traded up $2.48 during mid-day trading on Tuesday, reaching $78.34. 9,399,118 shares of the company traded hands, compared to its average volume of 11,744,468. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $91.45. The company has a fifty day moving average price of $64.71 and a 200-day moving average price of $59.20.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The business had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company's quarterly revenue was up 89.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. On average, analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Activity at Tempus AI

In related news, COO Ryan Fukushima sold 17,460 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $1,303,389.00. Following the completion of the transaction, the chief operating officer owned 839,180 shares in the company, valued at $62,644,787. This represents a 2.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO James William Rogers sold 7,528 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the transaction, the chief financial officer owned 138,473 shares of the company's stock, valued at approximately $10,337,009.45. This represents a 5.16% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,108,951 shares of company stock valued at $77,660,938 over the last 90 days. Company insiders own 26.27% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.